Clinical Trial Update: A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating BI 765128 in patients with diabetic retinopathy and diabetic macular ischemia who received laser treatment has posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• BI 765128

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Retinopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-27